Page last updated: 2024-10-21

pk 11195 and Epilepsy, Temporal Lobe

pk 11195 has been researched along with Epilepsy, Temporal Lobe in 2 studies

PK-11195 : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 1-(2-chlorophenyl)isoquinoline-3-carboxylic acid with the amino group of sec-butylmethylamine

Epilepsy, Temporal Lobe: A localization-related (focal) form of epilepsy characterized by recurrent seizures that arise from foci within the TEMPORAL LOBE, most commonly from its mesial aspect. A wide variety of psychic phenomena may be associated, including illusions, hallucinations, dyscognitive states, and affective experiences. The majority of complex partial seizures (see EPILEPSY, COMPLEX PARTIAL) originate from the temporal lobes. Temporal lobe seizures may be classified by etiology as cryptogenic, familial, or symptomatic. (From Adams et al., Principles of Neurology, 6th ed, p321).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bogdanović, RM1
Syvänen, S1
Michler, C1
Russmann, V1
Eriksson, J1
Windhorst, AD1
Lammertsma, AA1
de Lange, EC1
Voskuyl, RA1
Potschka, H1
Sauvageau, A1
Desjardins, P1
Lozeva, V1
Rose, C1
Hazell, AS1
Bouthillier, A1
Butterwort, RF1

Other Studies

2 other studies available for pk 11195 and Epilepsy, Temporal Lobe

ArticleYear
(R)-[11C]PK11195 brain uptake as a biomarker of inflammation and antiepileptic drug resistance: evaluation in a rat epilepsy model.
    Neuropharmacology, 2014, Volume: 85

    Topics: Animals; Anticonvulsants; Brain; Carbon Radioisotopes; Carrier Proteins; Chronic Disease; Disease Mo

2014
Increased expression of "peripheral-type" benzodiazepine receptors in human temporal lobe epilepsy: implications for PET imaging of hippocampal sclerosis.
    Metabolic brain disease, 2002, Volume: 17, Issue:1

    Topics: Epilepsy, Temporal Lobe; Hippocampus; Humans; Immunohistochemistry; In Vitro Techniques; Isoquinolin

2002